Pages that link to "Q87908797"
Jump to navigation
Jump to search
The following pages link to Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial (Q87908797):
Displaying 50 items.
- (Q87962169) (redirect page) (← links)
- Therapeutic Application of Chloroquine in Clinical Trials for COVID-19 (Q88978522) (← links)
- (Q89107103) (redirect page) (← links)
- Rising to the Challenge of the Novel SARS-coronavirus-2 (SARS-CoV-2): Advice for Pulmonary and Critical Care and an Agenda for Research (Q90593372) (← links)
- Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility (Q90682949) (← links)
- Chloroquine and COVID-19, where do we stand? (Q90685577) (← links)
- Potential Effects of Coronaviruses on the Cardiovascular System: A Review (Q90701727) (← links)
- Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future (Q90712071) (← links)
- The Late Arrival of COVID-19 in Africa - Mitigating Pan-Continental Spread (Q90750487) (← links)
- A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 (Q90750837) (← links)
- COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? (Q90766772) (← links)
- Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know (Q90784444) (← links)
- Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs (Q90785260) (← links)
- Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve (Q90788445) (← links)
- Combating COVID-19 with Chloroquine (Q90820639) (← links)
- Why the immune system fails to mount an adaptive immune response to a Covid -19 infection (Q90823458) (← links)
- Epidemiological analysis of COVID-19 and practical experience from China (Q90824691) (← links)
- Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution (Q90829379) (← links)
- Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence (Q90832566) (← links)
- Covid-19: Pandemonium in our time (Q90836536) (← links)
- Healthcare Database Networks for Drug Regulatory Policies: International Workshop on the Canadian, US and Spanish Experience and Future Steps for Italy (Q90894188) (← links)
- Anti-tuberculosis (TB) chemotherapy dynamically rescues Th1 and CD8+ T effector levels in Han Chinese pulmonary TB patients (Q91071501) (← links)
- Treatment options for COVID-19: The reality and challenges (Q91216197) (← links)
- No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection (Q91511871) (← links)
- To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic (Q91519936) (← links)
- Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic (Q91520031) (← links)
- Potential therapeutic agents against COVID-19: What we know so far (Q91531971) (← links)
- Coronaviruses and SARS-CoV-2: A Brief Overview (Q91532169) (← links)
- SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes (Q91538395) (← links)
- Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries (Q91564108) (← links)
- Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc) (Q91564121) (← links)
- A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19) (Q91565153) (← links)
- COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern? (Q91566417) (← links)
- Repurposing antimalarials and other drugs for COVID-19 (Q91569230) (← links)
- Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals (Q91573720) (← links)
- Macrolide treatment for COVID-19: Will this be the way forward? (Q91579431) (← links)
- COVID-19 and the Heart (Q91605297) (← links)
- Evidence synthesis relevant to COVID-19: a protocol for multiple systematic reviews and overviews of systematic reviews (Q91627661) (← links)
- Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients (Q91627965) (← links)
- COVID-19 And Older Adults: What We Know (Q91628073) (← links)
- Clinical trials on drug repositioning for COVID-19 treatment (Q91636659) (← links)
- COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: Prevention and Therapeutic Strategies (Q91662845) (← links)
- Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon (Q91702416) (← links)
- Coronavirus Disease (COVID-19): A primer for emergency physicians (Q91705550) (← links)
- Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review (Q91706276) (← links)
- COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? (Q91715293) (← links)
- Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes (Q91722563) (← links)
- COVID-19: Important Therapy Considerations and Approaches in this Hour of Need (Q91725814) (← links)
- COIVD 19 Disease: Tackling a pandemic in 21st Century (Q91728849) (← links)
- Response letter to COIVD-19 Disease: Tackling a pandemic in 21st Century (Q91728920) (← links)